EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Oral Complications of Systemic Therapies: A Narrative Review of Interdisciplinary Prevention and Management

Ghada Rashed Alotay, Mohammed Saleh Hummadi, Mousa Yahya Ahmad Hamdi, Fatimah Mufadhi Al-Anazi, Fatimah Mahboob Mohammad Manjahi, Ohoud Abdulkarim Alsahli, Khulud Abdulaziz Abdulaal, Mohammed Farhan Mohya Alhaysony, Turki Abdulaziz Mishaal Alalawi

Saudi Journal of Medicine and Public Health · 31.12.2024 · 1 (2) · 2417-2429

DOI: 10.64483/202412676 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Saudi Journal of Medicine and Public Health, online erschienen am 31.12.2024. Verfasst von Ghada Rashed Alotay und 8 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Systemic cancer therapies, including chemotherapy, targeted agents, and immunotherapies, frequently induce oral complications that significantly impair patients' quality of life, nutritional status, and treatment adherence. These complications range from oral mucositis and xerostomia to immune-related oral adverse events, requiring coordinated interdisciplinary management.

Aim

This narrative review synthesizes current evidence on the prevention, assessment, and management of oral complications associated with systemic cancer therapies, with emphasis on interdisciplinary collaboration among oncology nurses, dentists, pharmacists, and laboratory professionals.

Methods

A comprehensive literature search was conducted across PubMed, Scopus, and Web of Science for peer-reviewed articles published between 2010 and 2024, focusing on oral complications, assessment tools, preventive strategies, and interprofessional interventions.

Results

Evidence demonstrates that professional oral health care and patient education programs significantly reduce oral mucositis incidence and severity. Dental pre-treatment optimization, particularly allowing ≥2 weeks healing time for extractions, reduces osteoradionecrosis risk. Immune checkpoint inhibitors are associated with distinct oral toxicities, including xerostomia (5% prevalence), mucositis (3%), and dysgeusia (3%). Laboratory biomarkers, including single-nucleotide polymorphisms in XRCC1 and inflammatory cytokines, show promise for predicting mucositis risk. Pharmacist-led medication management and nursing assessment tools are essential for early detection and intervention.

Conclusion

Effective management of oral complications requires integrated interdisciplinary approaches, standardized assessment protocols, and personalized preventive strategies. Future research should focus on validating predictive biomarkers and optimizing interprofessional care models.

Zitieren

APA

Alotay, G. R., Hummadi, M. S., Hamdi, M. Y. A., Al-Anazi, F. M., Manjahi, F. M. M., Alsahli, O. A., Abdulaal, K. A., Alhaysony, M. F. M., & Alalawi, T. A. M. (2024). Oral Complications of Systemic Therapies: A Narrative Review of Interdisciplinary Prevention and Management. Saudi Journal of Medicine and Public Health, 1(2), 2417-2429. https://doi.org/10.64483/202412676

Vancouver

Alotay GR, Hummadi MS, Hamdi MYA, Al-Anazi FM, Manjahi FMM, Alsahli OA, et al. Oral Complications of Systemic Therapies: A Narrative Review of Interdisciplinary Prevention and Management. Saudi Journal of Medicine and Public Health. 2024;1(2):2417-2429. doi:10.64483/202412676

BibTeX
@article{Alotay2024,
  author = {Alotay, Ghada Rashed and Hummadi, Mohammed Saleh and Hamdi, Mousa Yahya Ahmad and Al-Anazi, Fatimah Mufadhi and Manjahi, Fatimah Mahboob Mohammad and Alsahli, Ohoud Abdulkarim and Abdulaal, Khulud Abdulaziz and Alhaysony, Mohammed Farhan Mohya and Alalawi, Turki Abdulaziz Mishaal},
  title = {Oral Complications of Systemic Therapies: A Narrative Review of Interdisciplinary Prevention and Management},
  journal = {Saudi Journal of Medicine and Public Health},
  year = {2024},
  volume = {1},
  number = {2},
  pages = {2417--2429},
  doi = {10.64483/202412676}
}
Kostenlos starten →